LED Medical Diagnostics Reports Successful Results for Latest Clinical Research Using VELscope® Tissue Fluorescence Technology

LED Medical Diagnostics Inc. (TSXV:LMD, OTCQX: LEDIF) reported that the results of a study, titled “Fluorescence Visualization-Guided Surgery for Early-Stage Oral Cancer”, have been published in the Journal of the American Medical Association – Otolaryngology – Head and Neck Surgery.
According to the company press release:

The publication reports the findings of a retrospective, case-control observational study that was conducted on 246 patients from September 1, 2004, to August 31, 2009. The study showed a significant reduction in the rate of local recurrence of early-stage squamous cell carcinoma and high-grade precancerous lesions in patients where VELscope tissue fluorescence visualization was used to assist in determining the surgical margin for excision, compared to those patients where conventional methods were used.

Dr. Catherine Poh, principal investigator and Provincial Oral Medicine Leader for Oral Oncology at the BC Cancer Agency commented:

This is really a revolutionary way for surgeons to visualize a diseased region. We are now working with head and neck surgeons across Canada to conduct a multi-center trial that will convince the world to change practice and improve the treatment of oral cancer.

Dr. David Gane, CEO of LED commented:

The results of this important clinical study will be of great interest to oral cancer patients and practitioners alike. It adds to the growing body of peer reviewed literature that corroborates the use VELscope as an effective adjunct in oral cancer treatment, while further supporting its use in concert with a comprehensive oral examination to screen for the presence of oral cancers and pre cancers.

Click here to view the full press release.